Ascorbic Acid Determination with an Automated Enzymatic Procedure (General Clinical Chemistry) Ascorbic Acid Determination with an Automated Enzymatic Procedure (General Clinical Chemistry)

Ascorbic Acid Determination with an Automated Enzymatic Procedure (General Clinical Chemistry‪)‬

Clinical Chemistry 1997, Jan, 43, 1

    • €2.99
    • €2.99

Publisher Description

A wide variety of methods involving different chromophores, detection systems, and enzymes has been developed for the determination of ascorbic acid (AA) and dehydroascorbic acid (DHAA) in biological samples. (1) The different principles involved have been reviewed and critiqued by Washko et al. [1]. In recent years HPLC has become the preferred method of determination, but this method has the disadvantages of being relatively labor intensive and costly for a clinical laboratory. In fact, very few currently available AA assays are ideally suited to the clinical laboratory. One such procedure, which is based upon measurement of an enzymatic reaction rate and involves a Beckman Synchron CX5 analyzer, has been previously described by Tulley [2]. Given the increasing interest in nutrition testing, and especially in nutrients that serve as antioxidants such as AA, an automated procedure designed for the clinical laboratory is desirable. To meet this need, we have developed an easily adaptable procedure that has significant advantages over chromatographic and spectrophotometric methods. This enzymatic end point procedure was developed by using the Cobas Fara centrifugal analyzer. In principle, AA is selectively and completely oxidized to DHAA by AA oxidase. The product is then coupled with o-phenylenediamine (OPDA) to yield a chromophore, the absorbance of which is measured at 340 nm.

GENRE
Science & Nature
RELEASED
1997
1 January
LANGUAGE
EN
English
LENGTH
10
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
PROVIDER INFO
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
174.7
KB
Development and validation of HPLC method for simultaneous quantitative determination of Azilsartan medoxomil potassium and Chlorthalidone in human plasma Development and validation of HPLC method for simultaneous quantitative determination of Azilsartan medoxomil potassium and Chlorthalidone in human plasma
2014
Fundamentals of Analytical Toxicology Fundamentals of Analytical Toxicology
2020
Assay for Free and Total Carnitine in Human Plasma Using Tandem Mass Spectrometry (Technical Briefs) Assay for Free and Total Carnitine in Human Plasma Using Tandem Mass Spectrometry (Technical Briefs)
2000
Liquid Chromatography in Clinical Analysis Liquid Chromatography in Clinical Analysis
2008
Can Whole-Blood Samples Be Stored over 24 Hours Without Compromising Stability of C-Reactive Protein, Retinol, Ferritin, Folic Acid, And Fatty Acids in Epidemiologic Research?(Technical Briefs) (Clinical Report) Can Whole-Blood Samples Be Stored over 24 Hours Without Compromising Stability of C-Reactive Protein, Retinol, Ferritin, Folic Acid, And Fatty Acids in Epidemiologic Research?(Technical Briefs) (Clinical Report)
2005
Sample Preparation in LC-MS Bioanalysis Sample Preparation in LC-MS Bioanalysis
2019
Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report) Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report)
2002
DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs) DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs)
2004
Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs) Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs)
2003
High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial) High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial)
2008
Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs) Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs)
2005
Hemoglobin Variants and Hemoglobin [a.Sub.1C] Analysis: Problem Solved?(Editorial) Hemoglobin Variants and Hemoglobin [a.Sub.1C] Analysis: Problem Solved?(Editorial)
2003